Biosynthesis of Silver Nanoparticles Using L. Aerial Part and Root Extracts: Bioactivity, Biocompatibility, and Catalytic Potential
Authors
Affiliations
The aim of this research was the synthesis of silver nanoparticles (SPA- and SPR-AgNPs) using the aqueous extracts of the aerial (SPA) and the root (SPR) parts of the plant L., their characterization, reaction condition optimization, and evaluation of their biological and catalytic activity. UV-Vis spectroscopy, X-ray powder diffraction (XRPD), scanning electron microscopy with EDS analysis (SEM/EDS), and dynamic light scattering (DLS) analysis were utilized to characterize the nanoparticles, while Fourier transform infrared (FTIR) spectroscopy was used to detect some functional groups of compounds present in the plant extracts and nanoparticles. The phenolic and flavonoid contents, as well as the antioxidant activity of the extracts, were determined spectrophotometrically. The synthesized nanoparticles showed twice-higher activity in neutralizing 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) compared with the respective extracts. SPR-AgNPs exhibited strong antimicrobial activity against almost all of the tested bacteria (<0.0039 mg/mL) and fungal strains, especially against the genus (<0.0391 mg/mL). Moreover, they were fully biocompatible on all the tested eukaryotic cells, while the hemolysis of erythrocytes was not observed at the highest tested concentration of 150 µg/mL. The catalytic activity of nanoparticles toward Congo Red and 4-nitrophenol was also demonstrated. The obtained results confirm the possibility of the safe application of the synthesized nanoparticles in medicine and as a catalyst in various processes.
Green Silver Nanoparticles: An Antibacterial Mechanism.
Mikhailova E Antibiotics (Basel). 2025; 14(1).
PMID: 39858291 PMC: 11762094. DOI: 10.3390/antibiotics14010005.
Evaluation of Genotoxic and Hemolytic Effects of and Biomass Extracts on Human Blood Cells In Vitro.
dordevic N, Vukajlovic J, Milosevic-dordevic O, Mihailovic V, Sreckovic N, Rakonjac A Microorganisms. 2024; 12(11).
PMID: 39597597 PMC: 11596682. DOI: 10.3390/microorganisms12112208.
Zuniga-Miranda J, Carrera-Pacheco S, Gonzalez-Pastor R, Mayorga-Ramos A, Rodriguez-Polit C, Heredia-Moya J Pharmaceutics. 2024; 16(10).
PMID: 39458579 PMC: 11510252. DOI: 10.3390/pharmaceutics16101247.
Baran A, Ertas E, Firat Baran M, Eftekhari A, Gunes Z, Keskin C Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931439 PMC: 11206647. DOI: 10.3390/ph17060772.
Abdoli M, Khaledian S, Mavaei M, Hajmomeni P, Ghowsi M, Qalekhani F Sci Rep. 2024; 14(1):13941.
PMID: 38886391 PMC: 11183110. DOI: 10.1038/s41598-024-64468-9.